scholarly article | Q13442814 |
P2093 | author name string | John Wong | |
Chun Yeung | |||
Chung Mau Lo | |||
Chi Leung Liu | |||
Sheung Tat Fan | |||
Ronnie Tung Ping Poon | |||
Chi Ming Lam | |||
Wai Kei Yuen | |||
P2860 | cites work | Laparoscopy and laparoscopic ultrasonography avoid exploratory laparotomy in patients with hepatocellular carcinoma | Q74489435 |
Hepatectomy for hepatocellular carcinoma: toward zero hospital deaths | Q74604755 | ||
Left hepatic vein kinking after right trisegmentectomy: a potential cause of postoperative liver failure | Q74693068 | ||
Analysis of factors affecting outcome after hepatectomy of patients with liver cirrhosis and small hepatocellular carcinoma | Q77062103 | ||
Problems of hepatectomy in cirrhosis | Q77214453 | ||
Acute portal hypertension associated with liver resection. Analysis of early postoperative death | Q93629129 | ||
Extended hepatic resection: a 6-year retrospective study of risk factors for perioperative mortality. | Q31978020 | ||
Percutaneous portal vein embolization increases the feasibility and safety of major liver resection for hepatocellular carcinoma in injured liver | Q33181403 | ||
Transection of the oesophagus for bleeding oesophageal varices | Q34211834 | ||
Improved results of liver resection for hepatocellular carcinoma on cirrhosis give the procedure added value | Q34290128 | ||
An analysis of 412 cases of hepatocellular carcinoma at a Western center | Q34503813 | ||
Surgical resection of hepatocellular carcinoma in cirrhotic patients: prognostic value of preoperative portal pressure. | Q34735059 | ||
Morbidity and mortality after major hepatic resection in cirrhotic patients with hepatocellular carcinoma | Q36711824 | ||
Significance of liver size in hepatic surgery | Q36712794 | ||
Is surgery for large hepatocellular carcinoma justified? | Q39225087 | ||
Seven hundred forty-seven hepatectomies in the 1990s: an update to evaluate the actual risk of liver resection | Q40757028 | ||
Standardized measurement of the future liver remnant prior to extended liver resection: methodology and clinical associations | Q40764488 | ||
Criteria for safe hepatic resection | Q40982944 | ||
Total Vascular Exclusion for Major Hepatectomy in Patients With Abnormal Liver Parenchyma | Q41678629 | ||
Extended hepatectomy for hepatocellular carcinoma | Q43682948 | ||
Major hepatectomy for hepatocellular carcinoma in patients with an unsatisfactory indocyanine green clearance test | Q43968906 | ||
Extended left hepatectomy with vascular exclusion | Q44693245 | ||
Perioperative safety and prognosis in hepatocellular carcinoma patients with impaired liver function | Q45029393 | ||
Liver resection for hepatocellular carcinoma: indications, techniques, complications, and prognostic factors | Q45185796 | ||
Surgical treatment of hepatocellular carcinoma on cirrhosis: a Western experience. | Q47750308 | ||
Hospital mortality of major hepatectomy for hepatocellular carcinoma associated with cirrhosis. | Q48792946 | ||
No-mortality liver resection for hepatocellular carcinoma in cirrhotic and noncirrhotic patients: is there a way? A prospective analysis of our approach. | Q52204731 | ||
Peri-operative mortality in hepatic resection | Q67914179 | ||
Limited hepatic resection for selected cirrhotic patients with hepatocellular or cholangiocellular carcinoma: a prospective study | Q67916293 | ||
Personal experience with 411 hepatic resections | Q67946279 | ||
Poor prognoses following left hepatic trisegmentectomies for cancer | Q69358913 | ||
Major hepatic resection under total vascular exclusion | Q69647084 | ||
Limited Hepatic Resection Effective for Selected Cirrhotic Patients with Primary Liver Cancer | Q70183160 | ||
Human liver regeneration after major hepatic resection. A study of normal liver and livers with chronic hepatitis and cirrhosis | Q70185713 | ||
Surgical resection for small hepatocellular carcinoma | Q70897299 | ||
Resection of hepatocellular carcinoma in patients with cirrhosis | Q71231246 | ||
Portal triad clamping or hepatic vascular exclusion for major liver resection. A controlled study | Q71396849 | ||
Results of major hepatectomy for large primary liver cancer in patients with cirrhosis | Q72399379 | ||
Perioperative nutritional support in patients undergoing hepatectomy for hepatocellular carcinoma | Q72827904 | ||
Conservative hepatic resection for hepatocellular carcinoma of cirrhotic patients | Q73064058 | ||
Extended left hepatectomy | Q73157866 | ||
Effect of preoperative portal vein embolization on major hepatectomy for advanced-stage hepatocellular carcinomas in injured livers: a preliminary report | Q73295239 | ||
Liver resection without total vascular exclusion: hazardous or beneficial? An analysis of our experience | Q73435925 | ||
Useful stapling techniques in liver surgery | Q73480205 | ||
Transarterial chemoembolization for inoperable hepatocellular carcinoma and postresection intrahepatic recurrence | Q73492842 | ||
Measurement of liver volume and hepatic functional reserve as a guide to decision-making in resectional surgery for hepatic tumors | Q73857009 | ||
Anterior approach for major right hepatic resection for large hepatocellular carcinoma | Q73913008 | ||
Factors affecting survival and long-term outcome in the cirrhotic patient undergoing hepatic resection for hepatocellular carcinoma | Q73938072 | ||
Postoperative adjuvant chemotherapy after curative resection of hepatocellular carcinoma: a randomized controlled trial | Q74250283 | ||
Operative risks of major hepatic resections | Q74296727 | ||
Risk of major liver resection in patients with underlying chronic liver disease: a reappraisal | Q74452520 | ||
P433 | issue | 5 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | hepatocellular carcinoma | Q1148337 |
P304 | page(s) | 602-611 | |
P577 | publication date | 2002-11-01 | |
P1433 | published in | Annals of Surgery | Q4767866 |
P1476 | title | Extended hepatic resection for hepatocellular carcinoma in patients with cirrhosis: is it justified? | |
P478 | volume | 236 |
Q47139016 | A prediction model for the grade of liver fibrosis using magnetic resonance elastography |
Q80213158 | Anatomic wide hepatectomy for treatment of hepatocellular carcinoma |
Q47642521 | Assessment of liver perfusion and function by indocyanine green in the perioperative setting and in critically ill patients |
Q28068579 | Cancer and liver cirrhosis: implications on prognosis and management |
Q37602751 | Cancer stem cell markers correlate with early recurrence and survival in hepatocellular carcinoma |
Q38668212 | Central Hepatectomy Still Plays an Important Role in Treatment of Early-Stage Centrally Located Hepatocellular Carcinoma |
Q47122200 | Circulating tumor cells as liquid biomarker for high HCC recurrence risk after curative liver resection |
Q53526112 | Clinicopathological significance and prognostic value of the expression of the cancer stem cell marker CD133 in hepatocellular carcinoma: a meta-analysis. |
Q33935631 | Combined resection and radiofrequency ablation for multifocal hepatocellular carcinoma: prognosis and outcomes |
Q41659507 | Contemporary strategies in the management of hepatocellular carcinoma |
Q38410816 | Current management of hepatocellular carcinoma: an Eastern perspective |
Q92559254 | Early versus late recurrence of centrally located hepatocellular carcinoma after mesohepatectomy: A cohort study based on the STROBE guidelines |
Q34998414 | Effect and safety of interferon for hepatocellular carcinoma: a systematic review and meta-analysis |
Q26751300 | Hepatic resection beyond barcelona clinic liver cancer indication: When and how |
Q36066056 | Hepatic resection in 170 patients using saline-cooled radiofrequency coagulation |
Q54521560 | Hepatic stiffness measurement by using MR elastography: prognostic values after hepatic resection for hepatocellular carcinoma. |
Q33881131 | Hepatocellular carcinoma: early-stage management challenges |
Q98386397 | High expression of endothelial progenitor cell-induced angiogenic markers is associated with bile acid levels in HCC |
Q35110692 | Impact of Glissonean pedicle approach for centrally located hepatocellular carcinoma in mongolia |
Q37430985 | Improved long-term survival after major resection for hepatocellular carcinoma: a multicenter analysis based on a new definition of major hepatectomy. |
Q33362747 | Improving perioperative outcome expands the role of hepatectomy in management of benign and malignant hepatobiliary diseases: analysis of 1222 consecutive patients from a prospective database |
Q38224452 | Indications, limitations and maneuvers to enable extended hepatectomy: current trends |
Q39341703 | Inferior right hepatic vein-preserving major right hepatectomy for hepatocellular carcinoma in patients with significant fibrosis or cirrhosis |
Q37728257 | Is there a standard for surgical therapy of hepatocellular carcinoma in healthy and cirrhotic liver? A comparison of eight guidelines. |
Q84862562 | Laparoscopic versus open liver surgery: a single center analysis of post-operative in-hospital and post-discharge results |
Q52857596 | Left hepatic trisectionectomy for hepatobiliary malignancy: results and an appraisal of its current role. |
Q50072154 | Liver Resection and Surgical Strategies for Management of Primary Liver Cancer |
Q89282055 | Liver Resection for Hepatocellular Carcinoma in Patients with Renal Dysfunction |
Q37148509 | Liver surgery in the presence of cirrhosis or steatosis: Is morbidity increased? |
Q43567099 | Liver trisectionectomies for primary and secondary liver cancer in the modern era: results of a single tertiary center |
Q53055843 | Liver-to-spleen ratio as an index of chronic liver diseases and safety of hepatectomy: a pilot study. |
Q55411511 | Long term survival analysis of hepatectomy for neuroendocrine tumour liver metastases. |
Q46619607 | Major hepatectomy is a safe modality for the treatment of intrahepatic cholangiocarcinoma in selected patients complicated with cirrhosis |
Q36955647 | Management of hepatocellular carcinoma: Enlightening the gray zones. |
Q33932728 | Mesohepatectomy for the treatment of patients with centrally located hepatocellular carcinoma |
Q53824659 | Modification of acid-base balance in cirrhotic patients undergoing liver resection for hepatocellular carcinoma. |
Q41081521 | Morbidity of hepatic resection for intermediate and advanced hepatocellular carcinoma |
Q42238762 | Nardilysin promotes hepatocellular carcinoma through activation of signal transducer and activator of transcription 3. |
Q82556153 | New indication for reduction surgery in patients with advanced hepatocellular carcinoma with major vascular involvement |
Q38060642 | New paradigms in post-hepatectomy liver failure |
Q90068282 | Optimizing hepatectomy for hepatocellular carcinoma in Asia-patient selection and special considerations |
Q35469039 | Outcomes of hepatectomy for hepatocellular carcinoma with bile duct tumour thrombus |
Q37278294 | Prediction of postoperative hepatic insufficiency by liver stiffness measurement (FibroScan((R))) before curative resection of hepatocellular carcinoma: a pilot study |
Q37467907 | Preoperative aspartate aminotransferase-to-platelet ratio index (APRI) is a predictor on postoperative outcomes of hepatocellular carcinoma |
Q37697192 | Prognostic nutritional index predicts short-term outcomes after liver resection for hepatocellular carcinoma within the Milan criteria |
Q42101721 | Quantitative Assessment of the Portal Pressure for the Liver Surgery Using Serological Tests. |
Q81591587 | Radiofrequency ablation versus surgical resection for the treatment of hepatocellular carcinoma in cirrhosis |
Q34127536 | Radiomorphology of the Habib sealer-induced resection plane during long-time followup: a longitudinal single center experience after 64 radiofrequency-assisted liver resections. |
Q50618597 | Real-time intraoperative assessment of residual liver functional reserve using pulse dye densitometry. |
Q39791598 | Referrals for surgical therapy in patients with hepatocellular carcinoma: a community experience |
Q44732885 | Risk factors influencing postoperative outcomes of major hepatic resection of hepatocellular carcinoma for patients with underlying liver diseases |
Q26795530 | Strategies to increase the resectability of hepatocellular carcinoma |
Q54989355 | Surgical Treatment of Hepatocellular Carcinoma. |
Q42177882 | Survival advantage of primary liver transplantation for hepatocellular carcinoma within the up-to-7 criteria with microvascular invasion |
Q38122362 | Systematic review of surgical resection vs radiofrequency ablation for hepatocellular carcinoma |
Q40788830 | The Negative Effect of Preoperative Transcatheter Arterial Chemoembolization on Long-Term Outcomes for Resectable Hepatocellular Carcinoma: A Propensity Score Matching Analysis |
Q36663840 | Three-Dimensional Quantitative Evaluation of the Segmental Functional Reserve in the Cirrhotic Liver Using Multi-Modality Imaging |
Q51848383 | Validation of the estimation of physiologic ability and surgical stress (E-PASS) score in liver surgery. |
Search more.